GC patients with high expression of NFKB2, REL, RELA, and RELB possessed a significantly shorter OS and first progression (FP) than patients with low expression of these four genes, while similar significance has not been observed for NFKB1 (Figures 1(b)–1(f)). Here, RELB is linked to gastric cancer.